HOME >> MEDICINE >> NEWS
Favorable outcomes from mild invitro fertilization practices

Mild in-vitro fertilisation* (IVF) can achieve the same chance of a pregnancy resulting in term livebirth as standard IVF**, but can also reduce patients' discomfort, multiple pregnancies, and costs, according to an Article published in this week's issue of The Lancet.

IVF is a complex treatment for infertility that entails costly regimes for ovarian stimulation, serious discomfort to patients, and substantial risks of complications. Strategies with shorter ovarian stimulation protocolssuch as gonadotropin-releasing hormone (GnRH) antagonist cotreatmentand transfer of a single embryo could allow more IVF cycles in the same period as conventional treatment, and produce a similar proportion of livebirths. Moreover, such mild strategies could reduce patients' discomfort and diminish the costs associated with multiple pregnancies.

Bart Fauser (University Medical Centre, Utrecht, Netherlands) and colleagues did a randomised trial to compare mild IVF treatment with standard IVF treatment in 404 patients. The 1-year cumulative proportion of pregnancies leading to livebirths was much the same with a mild strategy of IVF (43.4%) as with the standard IVF strategy (44.7%). The proportion of couples with multiple pregnancy outcomes was 0.5% with mild treatment versus 13.1% with standard treatment, and mean costs were 8333 and 10745 respectively. There were no significant differences between the groups in the anxiety, depression, physical discomfort, or sleep quality of the mother.

The authors conclude: "Our findings should encourage more widespread use of mild ovarian stimulation and single embryo transfer in clinical practice. However, adoption of our mild IVF treatment strategy would need to be supported by counselling both patients and health-care providers to redefine IVF success and explain the risks associated with multiple pregnancies, and by institution of reimbursement systems that encourage, rather than penalise, the practice of singl
'"/>

Contact: Professor Bart Fauser
b.c.fauser@umcutrecht.nl
31-302-507-524
Lancet
1-Mar-2007


Page: 1 2

Related medicine news :

1. Comparison of obstetric outcomes between on-call and patients own obstetricians
2. LSUHSC awarded designation resulting in improved patient safety and outcomes
3. Treatment outcomes of patients with HIV and tuberculosis
4. Liver cancer patients with high serum levels of hepatitis B virus face poorer outcomes
5. Long-term anti-clotting therapy sweetens stenting outcomes in diabetic patients
6. Acute coronary syndrome therapy improvements linked with fewer deaths and improved clinical outcomes
7. Disease management programs improve long-term outcomes
8. Comparison of 4 diet plans shows better outcomes for diet with lowest carbohydrate intake
9. High-power MRI helps Mayo Clinic surgical team predict outcomes in unusual tumor cases
10. Most hospital performance measures for heart failure not linked to improved patient outcomes
11. Psychological treatments improve outcomes for back pain sufferers

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Favorable outcomes from mild invitro fertilization practices

(Date:5/23/2013)... Heights,OH (PRWEB) May 23, 2013 Angeline Jolie’s ... genetic study showing there was an 87% chance she would ... odds of getting breast cancer. Long term studies show American ... during their lifetime (1). , Among the things that ... alcohol (more than a drink a day) smoking, and avoiding ...
(Date:5/23/2013)... According to the Centers for Disease Control, heart ... America today and is the leading cause of death in ... in the United States each year of heart disease, translating ... to profile the status of the cardiovascular system, with cholesterol ... the false assumption that if cholesterol levels are good, this ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 US ... 5.1 percent annually to $8.0 billion in 2017. ... the increasing need for high-performance plastic films that ... and chemical resistance in packaging and construction applications. ... market areas such as photovoltaic modules biodegradable products, ...
(Date:5/23/2013)... 23, 2013 Dr. Garber's Natural ... specific remedies are now available at Whole Foods Laguna ... 92677. The line of natural biotherapy formulas continues to ... , Represented by Brandstorm HBC (Los Angeles, CA), the ... throughout California, Nevada and Arizona, as well as Lassen's ...
(Date:5/23/2013)... York (PRWEB) May 23, 2013 Spring is ... Assisi Veterinary Hospital urges pet owners to be aware of ... treatments for pet allergies. , An allergy is a state ... called an allergen. Allergen exposure may cause an over-reaction. This ... against infection and disease, can actually be harmful to the ...
Breaking Medicine News(10 mins):Health News:Angelina Jolie has Women Asking for Ways to Reduce the Risk of Breast Cancer 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Safe and Healthy New Fast Weight Loss Alternative for At-Risk Heart Disease Patients 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Safe and Healthy New Fast Weight Loss Alternative for At-Risk Heart Disease Patients 3Health News:U.S. Specialty Films Market Worth $8 Billion & Packaging Drives Industry by 2017 Says New Research Report at ReportsnReports.com 2Health News:U.S. Specialty Films Market Worth $8 Billion & Packaging Drives Industry by 2017 Says New Research Report at ReportsnReports.com 3Health News:U.S. Specialty Films Market Worth $8 Billion & Packaging Drives Industry by 2017 Says New Research Report at ReportsnReports.com 4Health News:Dr. Garber's Natural Solutions Now Available at Whole Foods Market, Laguna Niguel, CA 2Health News:Allergy Season Affects Pets as Well as People 2
(Date:5/22/2013)... 2013  Aribex, Inc., manufacturer of the newly released ... new color option, black with gray trim, of the ... markets. The popular white with light blue trim Pro ... be available and both models can be purchased from ... http://photos.prnewswire.com/prnh/20130522/CL19573 ) "Dental offices are adding ...
(Date:5/22/2013)... , May 22, 2013 Attorney ... potential claims on behalf of purchasers of the ... "Company") (NasdaqGS: AMAG -News).  The investigation focuses on ... securities laws. On May 22, 2013, ... intraday trading after the company announced in regulatory ...
(Date:5/22/2013)... and CAESAREA, Israel , May 22, ... New clinical data presented from the DEFLECT-I study demonstrates ... reduces brain lesion volume during TAVR (Transcatheter Aortic Valve ... Keystone Heart Scientific Advisory Board announces consensus on the ... regarding the importance and need for cerebral protection during ...
Breaking Medicine Technology:Aribex Unveils New Color of NOMAD Pro 2 2Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. 2New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 2New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 3New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 4
Cached News: